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Paternally Expressed Peg3 Controls Maternally Expressed
Zim1 as a Trans Factor
An Ye, Hongzhi He, Joomyeong Kim*
Department of Biological Sciences, Louisiana State University, Baton Rouge, LA, United States of America

Abstract
The expression of two adjacent imprinted genes, Peg3 and Zim1, is inversely correlated: down-regulation of Peg3 coinciding
with up-regulation of Zim1. The current study characterized this inverse correlation using a mutant allele targeting Peg3.
According to the results, the mutation on the paternal allele of Peg3 resulted in a dramatic increase in the transcription
levels of the maternal allele of Zim1, suggesting the involvement of unknown trans factors in this trans-allelic event.
Subsequent ChIP experiments revealed that the protein encoded by Peg3 itself binds to the zinc finger exon of Zim1, which
is modified with the repression mark H3K9me3. Interestingly, the levels of H3K9me3 on Zim1 are also reduced in the mutant
cells lacking the protein PEG3, suggesting potential roles for PEG3 in establishing H3K9me3 on Zim1. Reintroducing PEG3
into the mutant cell restored down-regulation of Zim1, confirming the predicted repressor role for Peg3 on Zim1. Overall,
these results demonstrated that paternally expressed Peg3 controls maternally expressed Zim1 as a trans factor. The current
study also provides the first case for the trans-allelic interaction of two oppositely imprinted genes through their gene
products.
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shared cis elements. As expected, this domain is regulated through
an ICR, termed the Peg3-DMR (Differentially Methylated
Region), the 4-kb genomic region surrounding the 1st exons of
Peg3 and Usp29 [6]. Deleting part of this ICR, the 2.5-kb
genomic region harboring multiple YY1 binding sites, caused
global changes in the expression levels and imprinting status of
several genes within this domain [7]. In particular, the expression
levels of Peg3 and Zim1 were affected in a dosage-dependent
manner: 4-fold down-regulation of Peg3 coinciding with 4-fold upregulation of Zim1. Interestingly, the observed up-regulation of
Zim1 was still derived from the maternal allele although the
mutation causing down-regulation of Peg3 was on the paternal
allele [7]. This trans-allelic outcome by a mutation has not been
observed before, and thus suggests the presence of different
regulatory mechanisms involving possible trans factors rather than
the known mechanisms involving shared cis-regulatory elements as
seen from the H19/Igf2 pair.
According to recent studies, Peg3 encodes a DNA-binding
protein with transcriptional repression function [8]. Given the
observed tight correlation between Peg3 and Zim1, it is possible
that Peg3 may control directly the transcription of Zim1 as a trans
factor. In this case, the absence or reduced protein levels of PEG3
might be responsible for the observed up-regulation of Zim1. To
further test this possibility, the Peg3/Zim1 pair was analyzed using
a new mutant model targeting Peg3. In this new model, the
mutation truncates the transcription of Peg3, thus removing the
PEG3 protein [9]. The results revealed that the removal of PEG3

Introduction
In mammalian imprinted domains, two genes with opposite
imprinting are quite often localized right next to each other, and
such examples include maternally and paternally expressed H19/
Igf2 and Gtl2/Dlk1. This genomic layout is related to the fact that
two genes are usually co-regulated through shared cis elements,
such as Imprinting Control Regions (ICRs) [1]. As such, one gene
is very closely associated with the other gene in terms of their
transcription levels and allele-specific expression patterns. This has
been well demonstrated through a series of mouse mutagenesis
experiments. For instance, mutating an endoderm-specific enhancer located in the 39-side of H19 caused down-regulation for
both H19 and Igf2 [2], yet repositioning this enhancer from the
downstream region of H19 to an intergenic region between the
two genes resulted in the reactivation of the silenced maternal
allele of Igf2, causing biallelic expression of Igf2 [3]. This has
been a basis for identifying an enhancer-blocking function of the
ICR that is located immediate upstream of H19 [4]. It is most
likely that similar regulatory mechanisms operate in the other
imprinted domains with this genomic layout, the juxtaposition of
two adjacent genes with opposite imprinting.
A similar genomic layout is also found in the Peg3 domain,
which contains 7 imprinted genes: paternally expressed Peg3,
Usp29, APeg3, Zfp264 and maternally expressed Zim1, Zim2,
Zim3 [5]. Among these genes, paternally expressed Peg3 and
maternally expressed Zim1 are localized right next to each other,
suggesting potential co-regulation of these two genes through
PLOS ONE | www.plosone.org
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mutation on the paternal allele of Peg3. Since both mutant alleles
share one common feature, the reduced protein levels of PEG3,
the observed up-regulation of Zim1 is most likely caused by the
changed protein levels of PEG3 in both mutant models.

through the mutation on the paternal allele caused up-regulation
of Zim1 without disrupting its maternal-specific expression. PEG3
also binds to the Zim1 locus as a trans factor, yet this binding by
PEG3 is closely associated with the histone modification mark
H3K9me3, suggesting a potential repression mechanism for
PEG3. More detailed results have been described in the following
sections.

PEG3 binds to the zinc finger exon of Zim1
Since Peg3 encodes a DNA-binding protein with repression
activity, we tested the possibility that the protein PEG3 may
control directly the transcription of Zim1 as a trans factor. As an
initial step, the binding of PEG3 to the Zim1 locus was investigated
using Chromatin ImmunoPrecipitation (ChIP) technique (Fig. 2).
For this series of ChIP experiments, 4 genomic regions were
selected to scan the entire locus of mouse Zim1: Region 1
(promoter), 2 (intron), 3 (zinc finger exon) and 4 (39-UTR)
(Fig. 2A). The primer set amplifying the promoter of Pgm2l1
(phosphoglucomutase 2-like 1) was also included as a positive
control since this region has been shown to be a target locus of the
PEG3 protein [8]. Three different sets of cross-linked chromatins
were immunoprecipitated with anti-PEG3 polyclonal antibodies.
First, the immunoprecipitated DNA from the two MEF cells
representing wild-type (WT) and mutant (KO) cells were
individually analyzed with PCR (Fig. 2B). As expected, the
enrichment at the Pgm2l1 locus was detected only in the WT cells
but not in the KO cells lacking PEG3, confirming the binding of
PEG3 to this locus and also the specificity of our ChIP
experimental system. The same set of immunoprecipitated DNA
was further tested using the 4 primer sets of Zim1. Although the
two sets, Region 2 and 4, detected some levels of the enrichment,
the detections were not specific to the WT cells, indicating nonspecific binding of the anti-PEG3 antibody to other unknown
proteins. On the other hand, the promoter region of Zim1 (Region
1) did not show any level of the enrichment, indicating no binding
of PEG3 to this region. In contrast, the zinc finger exon (Region 3)
showed much higher levels of the enrichment in the WT cells than
in the KO cells, indicating that the observed enrichment likely
represents the genuine binding of PEG3 to this region. This has
been further confirmed through a set of independent ChIP
experiments with a custom-made antibody against PEG3 (Figure
S2).
Another set of ChIP experiments was also performed using the
second set of chromatin prepared from the brains of the WT and
KO (+/2p) neonates (Fig. 3B). According to the results, the
enrichment at the promoter of Pgm2l1 was also detected higher
levels in the WT than in the KO sample, confirming again the
specificity of the anti-PEG3 antibody and the ChIP system. A
similar pattern of WT-specific enrichment was observed in both
Region 1 and 3, indicating the potential binding of PEG3 to these
regions. However, the enrichment at Region 3 is much more
obvious than Region 1. Also, the observed enrichment at Region 3
is consistent with the results from the MEF cells, thus confirming
the genuine binding of PEG3 to this region in the neonatal brain.
Finally, the third set of ChIP experiments were performed using
the chromatin prepared from the F1 hybrid between C57BL/6J
and PWD/PhJ (Fig. 3C). Restriction enzyme digestion scheme
was employed to differentiate the two alleles of the immunoprecipitated DNA. According to the results, the immunoprecipitated
DNA at Region 1 and 3 both were derived equally from the two
parental alleles, indicating that PEG3 likely binds to both alleles of
these two regions. Taken together, this series of ChIP experiments
concluded that PEG3 binds to the zinc finger exon of Zim1 on
both alleles, further supporting the possibility that PEG3 may
control directly the transcription of Zim1 as a trans factor.

Results
Removal of the PEG3 protein results in the up-regulation
of Zim1
According to the results from the previous study, deletion of part
of the Peg3-DMR derived a concurrent 4-fold down and upregulation of Peg3 and Zim1, respectively [7]. However, it is
currently unknown the causal relationship between the observed
down and up-regulation of the two genes since the mutation also
caused other changes within the Peg3 domain. To further clarify
the observed effects on the Peg3/Zim1 pair, a new mutant model
targeting Peg3 was used for the current study (Fig. 1A). This
model was originally constructed with a combinatory scheme of
knock-in/knock-out, thus will be referred to as a KO model
hereafter for the simplicity. In this model, the mutant allele carries
an expression cassette containing two ORFs (Open Reading
Frames) within its 5th intron of Peg3: the promoterless bgalactosidase gene and the neomycin resistance gene driven by
the human b-actin promoter [9]. Because of the two poly(A)
signals within the cassette, the mutant allele truncates the
transcription of Peg3, thus removing the PEG3 protein [9].
Subsequent global gene expression analyses revealed that a large
number of genes were affected by the removal of PEG3 protein in
both the embryos and placentas of 14.5 d.p.c. (days post coitum)
[9]. As expected, Zim1 was also found to be up-regulated in this
survey: 2-fold up-regulation in both tissues, which is consistent
with the results from the mutant allele deleting part of the Peg3DMR [7].
To further follow-up this initial result, we have derived a set of
mouse embryonic fibroblast (MEF) cells from the mutant animals.
Two litters of 14.5-dpc embryos were prepared through timed
mating of the female and male heterozygotes for the mutant allele
with male and female wild-type littermates, respectively. The first
litter inheriting the mutant allele maternally does not have any
mutational effects on Peg3 since Peg3 is expressed mainly from
the paternal allele. In contrast, the second litter inheriting the
mutant allele paternally has an effect on Peg3, removing the
PEG3 protein completely [9]. After genotyping and gender
determination, each MEF line from a given embryo was
individually cultured, and subsequently used for isolating total
RNA for RT-PCR analyses. According to the results from the
female set (Fig. 1B), the expression levels of Zim1 were 2.5-fold
greater in the paternal heterozyote cell (+/2p) than the wild type
cell (+/+). Since this mutant allele disrupts the transcription and
translation of Peg3 only, the observed up-regulation of Zim1 is
most likely an outcome of the removal of PEG3. We repeated this
series of expression analyses using another set of MEFs, which also
showed a consistent up-regulation of Zim1 (Figure S1). The
allele-specific expression of the observed up-regulation of Zim1
was also tested using the F1 hybrid animals obtained from the
inter-specific crossing of C57BL/6J and PWD/PhJ (Fig. 1C). The
results from the total RNA of the neonatal brain indicated that the
up-regulated expression of Zim1 was still derived from the
maternal allele. Overall, this series of expression analyses derived
a consistent outcome as seen from the other mutant allele, the upregulation of Zim1 on the maternal allele coinciding with the
PLOS ONE | www.plosone.org
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Figure 1. Removal of the PEG3 protein results in the up-regulation of Zim1. (A) Schematic representation of the genomic structure of
paternally expressed Peg3 and maternally expressed Zim1. In the mutant allele, a 7.1-kb cassette containing a promoterless b-galactosidase (b-Gal)
and human b-actin promoter-driven neomycin resistant gene (NeoR) has been inserted between exon 5 and 6 of Peg3. The inserted cassette is flanked
by two FRT sites (open ovals), thus can be removed through FLP-mediated recombination. (B) Expression analyses of Zim1 using a set of female
mouse embryonic fibroblast (MEF) cells that had been prepared through breeding female and male heterozygotes with their wild-type littermates.
The MEF cells with the wild-type and the heterozygote with the paternal transmission of the mutant allele were used for qRT-PCR. (C) Imprinting tests
of Zim1 using the neonatal brains of the F1 hybrid derived from the crossing of a male heterozygote C57BL/6J (B6) and a female PWD/PhJ (PWD)
breeder. The RT-PCR products from Zim1 were digested with DraI, showing two parental patterns (lane 1 and 2) as well as the maternal-specific
expression pattern from the two neonates with WT and KO (lane 3 and 4), respectively. Schematic representation of this imprinting test was shown
above the gel picture.
doi:10.1371/journal.pone.0108596.g001

levels at other genomic regions, such as the ICR of H19/Igf2,
were similar between the two MEF cells (Fig. 4BC). This
indicates that the observed reduction of H3K9me3 in the KO
cells is specific to the zinc finger exon of Zim1. Since H3K9me3 is
known to be a repression mark for transcription, the reduced levels
of H3K9me3 is also consistent with the observed up-regulation of
Zim1 in the KO cells lacking PEG3 (Fig. 1B). Overall, the
genomic region of Zim1 bound by PEG3 is closely associated with
H3K9me3, further suggesting that PEG3 might repress Zim1
through H3K9me3.

Reduced levels of H3K9me3 in the mutant cells lacking
PEG3
The mouse locus of Zim1 was carefully examined using the
genome browser (genome.ucsc.edu) to obtain hints regarding the
potential functional outcomes of the observed PEG3 binding.
Histone modification levels of H3K4me3 and H3K9me3 derived
from ES cells and whole brain tissues are presented as Fig. 4A.
This examination revealed that the zinc finger exon of Zim1 is
marked with the histone modification H3K9me3 (Fig. 4A).
Although this histone mark is relatively rare in gene-rich
euchromatic regions, it is well known that this modification is
quite often associated with the genomic regions encoding the
Kruppel-type zinc finger gene family [10]. Zim1 is a member of
this gene family [11], thus the detection of this histone mark at the
Zim1 locus is consistent with the pattern observed from previous
studies. This modification at Zim1 is most obvious in ES cells but
some levels of this modification are also detected in other cell
types, including adult whole brain. To further test a potential
connection between PEG3 binding and H3K9me3, the modification levels of this repression signal were compared between the
WT and KO cells. According to the results (Fig. 4B), the
modification levels of H3K9me3 at Region 3 were 2 fold lower in
the KO cells than those in the WT cells although the modification
PLOS ONE | www.plosone.org

Restoring the protein levels of PEG3 down-regulates
Zim1
To further test PEG3’s repressor role in the transcription of
Zim1, we performed the following set of in vitro transfection
experiments (Fig. 5). In the MEF KO (+/2p) cells, the
transcription of Peg3 is disrupted by the inserted cassette, which
is flanked by two FRT (Flippase Recombination Target) sites. The
vector construct expressing Flippase (FLP) was transiently transfected into the KO cells to remove the cassette, restoring the
transcription and translation of Peg3. This pool of cells was used
for measuring the expression levels of Zim1 along with a set of
control cells: the cells transfected with no vector (Mock) and a
3
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Green Florescent Protein vector (GFP) (Fig. 5). As shown in
Fig. 5B, the transient expression of FLP indeed removed the
inserted cassette based on the detection of a genomic fragment
without the inserted cassette. This removal of the cassette
subsequently restored the expression of Peg3 based on RT-PCR.
In these cells with the restored PEG3, the transcriptional levels of
Zim1 was 2.5 and 1.5-fold reduced as compared to those observed
from the two control cells (Fig. 5C). It is also prudent to mention
that the transcriptional levels of Zim1 were further reduced in the
set transfected with FLP than in the set with GFP. These results
demonstrated that the restored expression of Peg3 is responsible
for the down-regulation of Zim1, confirming again the inverse
correlation between Peg3 and Zim1. Down-regulation of Zim1
was further tested with the over-expression of Peg3 (Figure S3A).
The results confirmed the down-regulation of Zim1 (Figure S3B).
Overall, this series of transfection experiments confirmed that
PEG3 functions as a repressor for the transcription of Zim1.

Discussion
In the current study, we tested the possibility that paternally
expressed Peg3 may control the transcription of maternally
expressed Zim1 as a trans factor. According to the results, the
reduced protein levels of PEG3 is indeed responsible for the upregulation of Zim1. The PEG3 protein also binds to the zinc finger
exon of Zim1 that is marked with the repression mark H3K9me3.
Furthermore, the KO cells lacking PEG3 have the reduced levels
of H3K9me3 at the zinc finger exon of Zim1, suggesting that
PEG3 might control Zim1 through H3K9me3. In vitro transfection experiments further demonstrated that reintroducing the
PEG3 protein into the KO cells restores the down-regulation of

Figure 2. PEG3 binds to the zinc finger exon of Zim1. (A)
Genomic structure of Zim1 and the relative positions of the primer sets
used for ChIP experiments. The 8 exons of Zim1 are indicated with
vertical lines and boxes. (B) PEG3-ChIP experiments using the two sets
of chromatins prepared from WT and KO (+/2p) MEF cells. The DNA
from Inputs, Negative controls (Neg), and Immunoprecipitates with
anti-PEG3 antibody (PEG3 IP) was used for PCR amplification. This series
of ChIP experiments also included another locus, Pgm2l1, as a positive
control since this locus is known to be bound by PEG3.

Figure 3. PEG3 binds to both alleles of Zim1. (A) Genomic structure of Zim1 and the relative positions of the primer sets used for ChIP
experiments. (B) Peg3-ChIP experiments using the two sets of chromatins prepared from WT and KO (+/2p) neonatal brains. The DNA from Inputs,
Negative controls (Neg), and Immunoprecipitates with anti-PEG3 antibody (PEG3 IP) was used for PCR amplification. This series of ChIP experiments
also included another locus, Pgm2l1, as a positive control. (C) Allele test of PEG3-ChIP DNA. One set of chromatin derived from the F1 neonatal brain
of the interspecific crossing between a male C57BL/6J (B6) and female PWD/PhJ (PWD) was used for ChIP experiments. The DNA representing Region
1 and 3 were digested with TaqI and DraI, respectively, to differentiate two alleles. The restriction enzyme sites on both DNA fragments are shown
along with the schematic representation of these allele tests. The results indicated that the immunoprecipitated DNA at these regions were derived
equally from both alleles.
doi:10.1371/journal.pone.0108596.g003
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Figure 4. Reduced levels of H3K9me3 in the mutant cells lacking PEG3. (A) Histone modification profiles on the Zim1 locus. The histone
modification profiles of H3K4me3 and H3K9me3 derived from ES (upper) and whole brains (lower) are presented along with the exon structure of
Zim1. (B) H3K9me3-ChIP using the two sets of chromatins prepared from WT and KO (+/2p) MEF cells. The DNA from Inputs, Negative controls (Neg),
and Immunoprecipitates with anti-H3K9me3 antibody (H3K9me3 IP) was used for PCR amplification. This series of ChIP experiments included another
locus, the imprinting control region of H19, as a positive control since the paternal allele of this ICR is known to be modified with H3K9me3. (C) The
reduced levels of H3K9me3 on Zim1 were further analyzed with qPCR. Shown are the relative values of the immunoprecipitated DNA to the negative
controls derived from MEF cells. Region 1 does not show any difference whereas Region 3 shows reduced levels of H3K9me3 in KO compared to
those from WT.
doi:10.1371/journal.pone.0108596.g004

Zim1. Overall, these results confirm that paternally expressed
Peg3 controls maternally expressed Zim1 as a trans factor.
The imprinted gene pair of Peg3/Zim1 is unique based on the
following reasons. As seen in the other pairs of oppositely
imprinted genes, the transcriptional level of Peg3 is also inversely
correlated with those of Zim1 (Fig. 1B and Fig. 5). However, this
inverse correlation does not involve any change in their allelespecific expression pattern (Fig. 1C), which is quite different from
the other pairs of oppositely imprinted genes [1]. This suggests the
involvement of some unknown trans factors in the inverse
correlation between Peg3 and Zim1. The results form the current
study further indicated that the protein encoded by Peg3 itself is
likely this unknown trans factor (Fig. 2 and Fig. 3). According to
previous studies, Peg3 encodes a DNA-binding protein with
repression activity [8]. Also, there is a very tight inverse correlation
between Peg3 and Zim1: 4-fold down regulation of Peg3
coinciding with 4-fold up-regulation of Zim1 [7]. This line of
evidence supports the idea that Peg3 controls the transcription of
Zim1 as a trans factor. Nevertheless, the results from the current
study also confirm another important aspect of Zim1 that PEG3 is
unlikely involved in regulating the allele-specific expression of
Zim1 since the removal of PEG3 does not have any effect on the
maternal expression of Zim1. The observed PEG3-mediated
regulation of the transcriptional levels of Zim1 appears to be
separate from some unknown mechanisms controlling the
maternal-specific expression of Zim1. In summary, the transcription of Zim1 is regulated through two separate mechanisms: one

PLOS ONE | www.plosone.org

controlling the allele-specific expression and the other controlling
the expression level through PEG3 (Fig. 6).
The binding of PEG3 to the zinc finger exon of Zim1 is
consistent with several known facts about the evolutionary origin
of Peg3 as well as the repression mark H3K9me3. First, Peg3 is
localized in the middle of a Cys2His2-type zinc finger gene cluster
[12], yet Peg3 itself encodes a DNA-binding protein with C2H2
zinc finger motifs [8]. This suggests that Peg3 may have originated
from this type of zinc finger genes (ZNFs). The C2H2-type ZNFs
are known to interact the H3K9 methylase SETDB1 via the corepressor protein KAP-1 [13]. Thus, the binding of PEG3 to the
genomic region with the H3K9me3 modification makes sense
given the evolutionary origin of Peg3, and further implies that
PEG3 might still recruit SETDB1, possibly through the interaction
with KAP-1 (Fig. 6). Second, it is well known that ZNFs, such as
Zim1, are usually regulated through H3K9me3 [10]. This is
further supported by the fact that the zinc finger-coding region of
Zim1 is indeed modified by this repression mark in ES and other
somatic cells (Fig. 4A). Yet, the KO cells lacking PEG3 have the
reduced levels of H3K9me3 (Fig. 4B). This further suggests that
PEG3 likely controls the transcription of Zim1 through H3K9me3.
According to the results from the mutant mouse model targeting
Peg3, many placenta-specific gene families are also up-regulated
in the brains of KO mice, yet all of these gene families are known
to be regulated through similar repression mechanisms involving
H3K9me3 [9]. Therefore, it is most likely that PEG3’s regulation
on Zim1 may be also through H3K9me3.

5
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Figure 5. Restoring the protein levels of PEG3 down-regulates Zim1. (A) Genomic structure of the mutant allele of Peg3 and FLP-mediated
recombination scheme to restore the expression of Peg3. The inserted cassette is flanked by two FRT sites, thus can be removed by Flippase (FLP). (B)
Three pools of KO MEF cells were transfected with the following constructs: no vector as a mock control (lane 1), a Green Fluorescent Protein (GFP)
expression vector as a negative control (lane 2), and a FLP expression vector (lane 3). The total RNA isolated from these cells were analyzed with RTPCR to measure the expression levels of b-actin, Zim1, and Peg3. The bottom panel shows genotyping results confirming FLP-mediated
recombination of the mutant allele (Rev KO) and endogenous allele (WT) of Peg3. (C) The observed down-regulation of Zim1 was further analyzed
using qRT-PCR.
doi:10.1371/journal.pone.0108596.g005

Materials and Methods
Ethics Statement
All the experiments related to mice were performed in
accordance with National Institutes of Health guidelines for care
and use of animals, and also approved by the Louisiana State
University Institutional Animal Care and Use Committee
(IACUC), protocol #13-061.

Derivation of MEF (Mouse Embryonic Fibroblast) cells
Two litters of 14.5-dpc embryos were harvested through timed
mating of the male and female mutant mice heterozygous for the
KO allele with the female and male wild-type littermates,
respectively. The mutant allele of Peg3 used for the current study
has been previously reported and characterized in detail [9]. The
head portion and the red tissues were removed from the embryos,
and the remaining portions were minced with razor blades. These
minced tissues were transferred to a 15 mL conical tubes
containing 1 mL trypsin (Invitrogen, Cat. No. 25300062). After
5 min incubation at 37uC, the cells were harvested with
centrifugation, and later resuspended in 15 mL media (Life
technologies, Cat. No. 10566024). Finally, the resuspended
cells were plated onto a T-75 flask. MEF from each embryo
was first genotyped using the following primer set: Peg3-for
(59-ATGAGTCTCGATCCCAGGTATGCC-39) and LoxR
PLOS ONE | www.plosone.org

Figure 6. Paternally expressed Peg3 controls maternally
expressed Zim1 as a trans factor involving H3K9me3. Schematic
representation for Peg3’s functional role in transcriptional control of
Zim1. The gene product of paternally expressed Peg3 binds to the zinc
finger exon of maternally expressed Zim1 on both alleles, resulting in
transcriptional repression through H3K9me3. The protein PEG3 may
interact with some unknown proteins, such as KAP-1, to recruit SETDB1
for the H3K9me3 modification on the Zim1 locus. This role of Peg3 is
independent of the maternal-specific expression of Zim1, thus the
observed up-regulation of Zim1 is still derived from the maternal allele
of the Peg3 mutant animals.
doi:10.1371/journal.pone.0108596.g006

6

September 2014 | Volume 9 | Issue 9 | e108596

Peg3 Control on Zim1

(59-TGAACTGATGGCGAGCTCAGACC-39). The gender of
each MEF was also determined using the following primer set:
mSry-F (59-GTCCCGTGGTGAGAGGCACAAG-39) and mSryR (59-GCAGCTCTACTCCAGTCTTGCC-39).

The information regarding individual primer sequences is also
available (Data S1).

Chromatin ImmunoPrecipitation (ChIP) analyses

Figure S1 (A) A series of RT-PCR analyses using
another set of MEF cells show a consistent up-regulation
of Zim1 by the mutation on Peg3. This analysis was
performed using two internal controls, 28S and b-actin. (B) The
up-regulation of Zim1 in KO MEF cell was further analyzed using
qPCR.
(JPG)

Supporting Information

Chromatins were prepared from two different types of samples,
MEF and neonatal brains, according to the method previously
described [8]. In brief, the homogenized samples were first crosslinked with 1% formaldehyde for 20 mins, and then lysed with the
buffer containing protease inhibitor cocktail (Millipore, Cat.
No. 539131). The released nuclei were fractionated with sonication to a pool of DNA fragments size-ranging from 300 to
1,000 bp in length. The prepared chromatin was immunoprecipitated with the following two antibodies: PEG3 (Abcam, Cat.
No. ab99252) and H3K9me3 (Abcam, Cat. No. ab8898). Each
immunoprecipitated DNA was dissolved in 100 ml of TE for either
PCR or qPCR analyses.

Figure S2 (A) A set of independent ChIP experiments

with a custom-made anti-PEG3 antibody using the two
sets of chromatins prepared from WT and KO (+/2)
MEF cells. The DNA from Inputs, Negative controls (Neg), and
Immunoprecipitates with anti-PEG3 antibody (PEG3 IP) was used
for PCR amplification. This series of ChIP experiments also
included another locus, Pgm2l1, as a positive control. (B) qPCR
analyses using these ChIP DNA derived from MEF cells. Regions
2 and 3 showed some levels of the enrichment, but Region 3
showed the highest enrichment levels. However, no significant
enrichment was detected in Region 1. (C) Western blotting testing
the specificity of a new custom-made antibody using the two sets of
total protein prepared from WT and KO (+/2) MEF cells.
(JPG)

Transfection experiments
MEF cells were transfected with the following two constructs,
GFP (pIRES-puro-GFP) and FLP (pIRES-puro-FLP), using the
GenJect transfection reagent (Cat. No. SL100489-MEF) according to the manufacturer’s protocol. Transfection efficiency was
monitored through GFP expression under a fluorescence microscope after 24 hours. The transfected cells were harvested at 72hour post transfection for RNA and DNA isolation. The reverted
allele of Peg3 by FLP was detected through PCR with the
following
primer
set:
Flpko-F
(59-CCCTCAGCAGAGCTGTTTCCTGCC-39)
and
Flpko-R
(59-AAGCTACCTGGGAAATGAGTGTGG-39).

(A) Three pools of KO MEF cells were
transfected with the following constructs: No vector as
a mock control (lane1), PEG3 expression vector (Lane2),
and Green Fluorescent Protein (GFP) expression vector
as a negative control. The total RNA isolated from these cells
were analyzed with RT-PCR to measure the expression levels of
b-actin, Zim1 and Peg3. (B) The observed down-regulation of
Zim1 was further analyzed using qRT-PCR.
(JPG)
Figure S3

RNA isolation and qRT-PCR analyses
Total RNA was isolated from either MEF or the brains of oneday-old neonates using a commercial kit (Trizol, Invitrogen)
according to the manufacturer’s protocol. The total RNA was then
reverse-transcribed using the M-MLV kit (Invitrogen), and the
subsequent cDNA was used as a template for quantitative PCR.
The qRT-PCR analysis was performed with SYBR Select Master
Mix (Applied Biosystems, Life Technologies) using the iCycler
iQTM multicolor real-time detection system (Bio-Rad). All qRTPCR reactions were carried out for 40 cycles under standard PCR
conditions with internal controls (28S and b-actin). The results
derived from qRT-PCR were further analyzed using the threshold
(Ct) value. The DCt value was initially calculated by subtracting Ct
value of a testing replicate of a given gene from the average Ct
value of the internal control (28S and b-actin). The fold difference
for each replicate was then calculated by raising the DDCt value as
a power of 2 [14]. The average and standard deviation for each
sample were then calculated by compiling the normalized values.

Data S1 List of the primers that were used for ChIP and
qRT-PCR experiments.
(DOCX)
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